Mechanistic diversity and regulation of Type II fatty acid synthesis
The DOI matches its Crossref record.
Abstract
Fatty acid biosynthesis is catalysed in most bacteria by a group of highly conserved proteins known as the Type II fatty acid synthase (FAS) system. The Type II system organization is distinct from its mammalian counterpart and offers several unique sites for selective inhibition by antibacterial agents. There has been remarkable progress in the understanding of the genetics, biochemistry and regulation of Type II FASs. One important advance is the discovery of the interaction between the fatty acid degradation regulator, FadR, and the fatty acid biosynthesis regulator, FabR, in the transcriptional control of unsaturated fatty acid synthesis in Escherichia coli. The availability of genomic sequences and high-resolution protein crystal structures has expanded our understanding of Type II FASs beyond the E. coli model system to a number of pathogens. The molecular diversity among the pathway enzymes is illustrated by the discovery of a new type of enoyl-reductase in Streptococcus pneumoniae [enoyl-acyl carrier protein (ACP) reductase II, FabK], the presence of two enoyl-reductases in Bacillus subtilis (enoyl-ACP reductases I and III, FabI and FabL), and the use of a new mechanism for unsaturated fatty acid formation in S. pneumoniae (trans-2-cis-3-enoyl-ACP isomerase, FabM). The solution structure of ACP from Mycobacterium tuberculosis revealed features common to all ACPs, but its extended C-terminal domain may reflect a specific interaction with very-long-chain intermediates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Biosynthesis of Nonribosomal Peptides
Finking, R., & Marahiel, M. A. (2004) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123615 · Cited by 888
Mycolic Acids: Structures, Biosynthesis, and Beyond
Marrakchi, H., Lanéelle, M.-A., & Daffé, M. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.11.011 · Cited by 623
Self-citationVieler, A., Wu, G., Tsai, C.-H., Bullard, B., Cornish, A. J., Harvey, C., Reca, I.-B., Thornburg, C., Achawanantakun, R., Buehl, C. J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003064 · Cited by 458
Microbial Type I Fatty Acid Synthases (FAS): Major Players in a Network of Cellular FAS Systems
Schweizer, E., & Hofmann, J. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.3.501-517.2004 · Cited by 384
Regulation of lipid accumulation in oleaginous micro-organisms
Ratledge, C. (2002) · Biochemical Society Transactions · doi:10.1042/bst0301047 · Cited by 378
Cellulosic hydrolysate toxicity and tolerance mechanisms in Escherichia coli
Mills, T. Y., Sandoval, N. R., & Gill, R. T. (2009) · Biotechnology for Biofuels · doi:10.1186/1754-6834-2-26 · Cited by 347
Bacterial Membrane Lipids: Where Do We Stand?
Cronan, J. E. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090851 · Cited by 345
Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens
Brinster, S., Lamberet, G., Staels, B., Trieu-Cuot, P., Gruss, A., & Poyart, C. (2009) · Nature · doi:10.1038/nature07772 · Cited by 317
Uehling, J., Gryganskyi, A., Hameed, K., Tschaplinski, T., Misztal, P. K., Wu, S., Desirò, A., Vande Pol, N., Du, Z., Zienkiewicz, A., et al. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13669 · Cited by 173
“FAS pathways are divided into types I and II, which are predominant in either animals and fungi or bacteria and plants, respectively (Marrakchi et al ., 2002; Schweizer and Hofmann, 2004; Leibundgut et al ., 2008; Ploskon et al ., 2008).”
Production of free monounsaturated fatty acids by metabolically engineered Escherichia coli
Cao, Y., Liu, W., Xu, X., Zhang, H., Wang, J., & Xian, M. (2014) · Biotechnology for Biofuels · doi:10.1186/1754-6834-7-59 · Cited by 107
Metadata
- Authors
- Marrakchi, H., Zhang, Y.-M., & Rock, C. O.
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2002-11-01
- Volume
- 30
- Issue
- 6
- Pages
- 1050-1055
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- OpenAlex
- W1968220057
- Cited by
- 134
- References
- 0
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.